Regulatory affairs due diligence in EU

Challenge An established generics company looking to acquire the French rights of an existing product franchise needed to perform regulatory and clinical due diligence on the French dossier.
Learn More

Point of care diagnostics due diligence

Challenge A major European venture capital investor needed to analyze the business plan of a novel point-of-care diagnostics company.
Learn More

Development strategy and business support for an early-stage oncology company

Challenge After a seed investment, Evgen, a start-up biotech had built an IP portfolio in the field of glucosinolates, chemicals found in brassica vegetables, that are potent inducers of...
Learn More

Screening for rare disease licensing opportunities

Challenge Our client, a commercial stage biotech company focused on rare and ultra-rare diseases was seeking to build its pipeline of development products. Whilst it had an established business...
Learn More

Searching and assessing stem cell medicines

Challenge A listed North American firm needed support with the identification of early-stage in-licensing or acquisition opportunities in the highly competitive field of regenerative medicine....
Learn More

Providing search and assessment support for oncology projects

Challenge A listed North American company needed hands-on support with the identification, assessment and in-licensing of early-stage oncology assets.
Learn More

Searching for late stage therapeutics, devices and diagnostics acquisition targets in the US

Challenge A well-capitalized European pharma company needed on-the-ground support with a search for late stage therapeutics, devices and diagnostics acquisition opportunities in the US. Alacrita was...
Learn More

Scouting for early-stage oncology opportunities

Challenge A listed North American company needed support with the identification, assessment and in-licensing of early-stage oncology assets.
Learn More

Conducting IP due diligence

Challenge We have conducted multiple due diligence projects, below are three examples:
Learn More

Assessment of an AAV gene therapy for an ophthalmic indication

Challenge: Alacrita conducted an assessment of an AAV gene therapy for an ophthalmic indication, focusing on market potential, technical and regulatory issues and identification of key risks.
Learn More

Neuroscience Due Diligence

Alzheimer's due diligence Our client, a major pension fund, was considering an investment opportunity in a Phase III neuroscience company. The company was developing a small molecule to provide...
Learn More

Medical device technology assessment

A university research team had worked for a number of years on the development of a novel interventional cardiology device. Recent progress had been made with pre-clinical testing on pigs, as well as...
Learn More